Actively Recruiting

Age: 20Years - 80Years
All Genders
NCT06898996

FITting Non-invasive Tests in Lynch Syndrome Surveillance

Led by University of Chicago · Updated on 2026-04-16

400

Participants Needed

3

Research Sites

207 weeks

Total Duration

On this page

Sponsors

U

University of Chicago

Lead Sponsor

N

National Cancer Institute (NCI)

Collaborating Sponsor

AI-Summary

What this Trial Is About

The purpose of this clinical study is to evaluate the accuracy of the fecal immunochemical test (FIT) in comparison to colonoscopy in patients with Lynch Syndrome (LS) who are undergoing colonoscopy surveillance.

CONDITIONS

Official Title

FITting Non-invasive Tests in Lynch Syndrome Surveillance

Who Can Participate

Age: 20Years - 80Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Have a diagnosis of Lynch Syndrome with a confirmed pathogenic variant in MLH1, MSH2, MSH6, PMS2, or EPCAM genes.
  • Aged 20 to 80 years for those with variants in MLH1, MSH2, and EPCAM.
  • Aged 30 to 80 years for those with variants in PMS2 or MSH6.
  • Have an upcoming standard of care colonoscopy appointment following Lynch Syndrome surveillance guidelines.
  • Patients with previous colon surgery who still have 20cm or more of colon remaining.
  • Patients diagnosed with advanced neoplasia who have not had endoscopic or surgical resection.
  • Willing to sign informed consent, provide stool samples, and complete surveys.
Not Eligible

You will not qualify if you...

  • Individuals without confirmed genetic testing for Lynch Syndrome despite family history or criteria.
  • Individuals who have had subtotal or total colectomy.
  • Newly diagnosed Lynch Syndrome patients under 20 years old with variants in MLH1, MSH2, EPCAM, MSH6, or PMS2.
  • Newly diagnosed Lynch Syndrome patients under 30 years old with variants in MSH6 or PMS2.
  • Individuals who are pregnant.
  • Individuals with inflammatory bowel disease or active cancer.
  • Individuals unwilling or unable to sign informed consent.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 3 locations

1

The University of Chicago Medical Center

Chicago, Illinois, United States, 60639

Actively Recruiting

2

University of Michigan

Ann Arbor, Michigan, United States, 48109

Actively Recruiting

3

Columbia University

New York, New York, United States, 10032

Actively Recruiting

Loading map...

Research Team

S

Sonia Kupfer, MD

CONTACT

K

Kristi Kearney, RN

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here